4 Results for "

acute porphyrias

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "acute porphyrias" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-W040030
CAS No.: 15489-90-4
Target:  

Cytochrome P450

Research Areas:  

Metabolic Disease Cancer

Hematin, an iron-containing porphyrin, inhibits the activity of clotting factors and also fibrin clot lysis through the mechanism of binding to and inactivation of hemostatic proteins . Hematin can be used for the research of acute porphyrias and cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-132610
CAS No.: 1639325-43-1
Purity:  98.51%
Synonyms: ALN-AS1
Research Areas:  

Metabolic Disease

Givosiran (ALN-AS1) is a small interfering RNA that targets hepatic aminolevulinate synthase 1 (ALAS1) messenger RNA. Givosiran downregulates ALAS1 mRNA and prevents accumulation of neurotoxic δ-aminolevulinic acid (ALA) and porphobilinogen (PBG) levels. Givosiran demonstrates potent inhibitory activity against ALAS1 in mouse, rat, and cynomolgus monkey models. Givosiran can be used for the research of acute hepatic porphyria (AHP) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-132610A
CAS No.: 1639325-44-2
Purity:  98.51%
Synonyms: ALN-AS1 sodium
Research Areas:  

Metabolic Disease

Givosiran (ALN-AS1) sodium is a small interfering RNA that targets hepatic aminolevulinate synthase 1 (ALAS1) messenger RNA. Givosiran sodium downregulates ALAS1 mRNA and prevents accumulation of neurotoxic δ-aminolevulinic acid (ALA) and porphobilinogen (PBG) levels. Givosiran sodium demonstrates potent inhibitory activity against ALAS1 in mouse, rat, and cynomolgus monkey models. Givosiran sodium can be used for the research of acute hepatic porphyria (AHP) .
loading...
    loading...
Cat. No.: HY-150151A
Target:  

LYTACs

Research Areas:  

Cardiovascular Disease

GalNac-siRNA negative control (21nt) is the negative control form of GalNac-siRNA. GalNac-siRNA is an Asialoglycoprotein receptor (ASGPR)-targeted inhibitor conjugate. GalNac-siRNA is promising for research of hereditary transthyretin amyloidosis, acute hepatic porphyria, hemophilia and hypercholesterolemia .
loading...
    loading...